l-norleucine

Small moleculeexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2003 (NCT00081952)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • l-norleucine
  • l-norleucine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00081952Phase 1/Phase 2 (Phase 2)Oct 1, 2003National Center for Complementary and Integrative Health (NCCIH)
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Center for Complementary and Integrative Health (NCCIH)Government1112003
1 organizations
Page 1 / 1